![](/img/cover-not-exists.png)
Cost-Benefit Analysis of Riluzole for the Treatment of Amyotrophic Lateral Sclerosis
Dr Gary M. Ginsberg,Boaz LevVolume:
12
Language:
english
Journal:
PharmacoEconomics
DOI:
10.2165/00019053-199712050-00008
Date:
November, 1997
File:
PDF, 763 KB
english, 1997